LEMKEY JOHN G (Chief Financial Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2020ACC: 0001209191-20-000757
Officer· Chief Financial Officer
Since Jun 2018
+82.00
Net shares
Net buyer
$1.1K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
82.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+41.00
Price / share
$27.58
Trade value
$1.13K
% of position
1.9%
12/31/2019
2.18K→2.22K
Total
Net shares
+41.00
Net value
$1.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2019 | A · Award | +41.00 | $27.58 | $1.13K | 1.9% | 2.18K | 2.22K |
| Total | +41.00 | $1.13K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
41.00 shares
Shares
+41.00
Strike price
32.45
Held after
41.00
Exercisable
—
12/31/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock41.00 shares | 12/31/2019 | A · Award | +41.00 | 32.45 | — | 41.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned14.08M
Total
14.08M indirect14.08M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.08M | Indirect |
| Total | 14.08M | 14.08M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported